Resoconti Knight Therapeutics Inc. BOERSE MUENCHEN

Azioni

04K

CA4990531069

Tempo reale BOERSE MUENCHEN Altri mercati azionari 16:43:44 11/07/2024			Variaz. 5gg	Var. 1 gen.
3,82 ^EUR	0,00%		-1,55%	+6,70%

09/05	Knight Therapeutics sale di quasi il 3% dopo l'annuncio dell'accordo di fornitura e distribuzione per il farmaco ADHD; nonostante un Q1 contrastato	MT
09/05	Transcript : Knight Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024

Resoconti

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Transcript : Knight Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024	09/05
Transcript : Knight Therapeutics Inc., Q4 2023 Earnings Call, Mar 21, 2024	21/03
Transcript : Knight Therapeutics Inc., Q3 2023 Earnings Call, Nov 09, 2023	09/11
Transcript : Knight Therapeutics Inc., Q2 2023 Earnings Call, Aug 10, 2023	10/08/23
Transcript : Knight Therapeutics Inc., Q1 2023 Earnings Call, May 11, 2023	11/05/23
Transcript : Knight Therapeutics Inc. - Shareholder/Analyst Call	10/05/23
Transcript : Knight Therapeutics Inc., Q4 2022 Earnings Call, Mar 23, 2023	23/03/23
Transcript : Knight Therapeutics Inc., Q3 2022 Earnings Call, Nov 10, 2022	10/11/22
Transcript : Knight Therapeutics Inc., Q2 2022 Earnings Call, Aug 11, 2022	11/08/22
Transcript : Knight Therapeutics Inc., Q1 2022 Earnings Call, May 12, 2022	12/05/22
Transcript : Knight Therapeutics Inc. - Shareholder/Analyst Call	11/05/22
Transcript : Knight Therapeutics Inc., Q4 2021 Earnings Call, Mar 24, 2022	24/03/22
Knight Therapeutics Inc. Fornisce la previsione delle entrate per l'anno fiscale 2022	24/03/22	CI
Transcript : Knight Therapeutics Inc., Q3 2021 Earnings Call, Nov 11, 2021	11/11/21
Transcript : Knight Therapeutics Inc., Q2 2021 Earnings Call, Aug 13, 2021	13/08/21
Transcript : Knight Therapeutics Inc., Q1 2021 Earnings Call, May 14, 2021	14/05/21
Transcript : Knight Therapeutics Inc. - Special Call	23/04/21
Transcript : Knight Therapeutics Inc., Q4 2020 Earnings Call, Mar 25, 2021	25/03/21
Transcript : Knight Therapeutics Inc., Q3 2020 Earnings Call, Nov 13, 2020	13/11/20
Transcript : Knight Therapeutics Inc., Q2 2020 Earnings Call, Aug 13, 2020	13/08/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Resoconti Knight Therapeutics Inc. BOERSE MUENCHEN

Azioni

04K

CA4990531069

Resoconti

Filtri